IRWD
IRWD clinical trials: IRONWOOD PHARMACEUTICALS INC
Every trial on ClinicalTrials.gov where IRONWOOD PHARMACEUTICALS INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 42
- Trials linked
- 25
- As lead sponsor
- 17
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
IRWD on the catalyst calendar · IRWD registry changes
- Primary completion Jan 23, 2025ActualPhase 2NCT05740007A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeIronwood Pharmaceuticals, Inc. · Interstitial CystitisTerminatedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2022ActualPhase 1NCT05362695A Study of Multiple-ascending Doses of IW-3300 in Healthy SubjectsIronwood Pharmaceuticals, Inc. · Healthy VolunteersCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 9, 2022ActualPhase 1NCT05188261A Study of Single Ascending Doses of IW-3300 in Healthy VolunteersIronwood Pharmaceuticals, Inc. · Healthy VolunteersCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2010ActualPhase 2NCT01107236Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar ExtractionIronwood Pharmaceuticals, Inc. · HealthyCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2018ActualPhase 4NCT02837783A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)Ironwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome Characterized by ConstipationTerminatedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 25, 2019ActualPhase 4NCT03226899A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal ImpairmentIronwood Pharmaceuticals, Inc. · GoutTerminatedIRWDLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 7, 2020ActualPhase 3NCT03561090A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)Ironwood Pharmaceuticals, Inc. · Gastroesophageal Reflux Disease (GERD)TerminatedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2020ActualPhase 3NCT03561883Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)Ironwood Pharmaceuticals, Inc. · Gastroesophageal Reflux Disease (GERD)CompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2020ActualPhase 2NCT03931785A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel SyndromeIronwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedIRWDLeadABBVCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2019ActualPhase 3NCT03573908A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)Ironwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome Characterized by ConstipationCompletedIRWDLeadABBVCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2016ActualPhase 2NCT02559206Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)Ironwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome With ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 26, 2017ActualPhase 2NCT02637557A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)Ironwood Pharmaceuticals, Inc. · Gastroesophageal Reflux DiseaseCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 25, 2019ActualPhase 1NCT03856970Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy...Ironwood Pharmaceuticals, Inc. · Healthy VolunteersCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2012ActualPhase 3NCT00730171An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With ConstipationIronwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome With ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2015ActualPhase 3NCT02291679Trial of Linaclotide in Patients With Chronic Idiopathic ConstipationIronwood Pharmaceuticals, Inc. · Chronic Idiopathic ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 2NCT02289846Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)Ironwood Pharmaceuticals, Inc. · Diabetic GastroparesisCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2014ActualPhase 2NCT02030925Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump InhibitorsIronwood Pharmaceuticals, Inc. · Gastroesophageal RefluxCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2014ActualPhase 2NCT01712412Phase 2a Study of IW-9179 to Treat Functional DyspepsiaIronwood Pharmaceuticals, Inc. · DyspepsiaTerminatedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2010ActualPhase 3NCT00938717Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)Ironwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome With ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2008ActualPhase 2NCT00460811Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With...Ironwood Pharmaceuticals, Inc. · Irritable Bowel Syndrome With ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00402337Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic ConstipationIronwood Pharmaceuticals, Inc. · Chronic ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2009ActualPhase 3NCT00730015Trial of Linaclotide in Patients With Chronic ConstipationIronwood Pharmaceuticals, Inc. · Chronic ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00306748Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic ConstipationIronwood Pharmaceuticals, Inc. · ConstipationCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00404001Study of Oral MD-0727 Administered to Patients With Primary HypercholesterolemiaIronwood Pharmaceuticals, Inc. · HypercholesterolemiaCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00258193Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBSIronwood Pharmaceuticals, Inc. · Irritable Bowel SyndromeCompletedIRWDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 17 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner